RecruitingNot ApplicableNCT06109870

Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening


Sponsor

M.D. Anderson Cancer Center

Enrollment

920 participants

Start Date

Oct 30, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Cervical cancer is a disease that is preventable through vaccination against the virus that causes it, human papillomavirus (HPV), and through screening and treatment of cervical disease before it becomes cancet.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests a community-based strategy to improve access to cervical cancer screening for women in underserved areas of Texas (the Rio Grande Valley and similar communities). Participants receive at-home HPV self-testing kits and support to make screening easier. **You may be eligible if...** - You are a woman aged 25 or older - You currently live in the Rio Grande Valley or another low-resource Texas community - You have not had a Pap test in over 3.5 years, or a Pap/HPV co-test in over 5.5 years - You have a cervix (no prior hysterectomy with cervix removal) - You have no history of cervical cancer or high-grade cervical abnormalities **You may NOT be eligible if...** - You are unable to communicate in English or Spanish - You do not have valid phone contact information - You are currently pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPRECEDE-PROCEED

delivered self-sampling (CHWSS) to increase screening participation.


Locations(2)

University of Texas at Austin

Austin, Texas, United States

M D Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06109870


Related Trials